2-AMino-9-(2-C-Methyl-β-D-ribofuranosyl)-9H-purine manufacturers
|
| | 2-AMino-9-(2-C-Methyl-β-D-ribofuranosyl)-9H-purine Basic information |
| Product Name: | 2-AMino-9-(2-C-Methyl-β-D-ribofuranosyl)-9H-purine | | Synonyms: | 9-(2-C-Methyl-beta-D-ribofuranosyl)-9H-purin-2-amine;(2R,3R,4R,5R)-2-(2-Amino-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol;9H-Purin-2-amine, 9-(2-C-methyl-β-D-ribofuranosyl)-;2-Amino-9-(2-C-methyl-β-D-ribofuranosyl)-9H-purine;2-Ami no-9-(2-b-C-methyl-β-D-ribofuranosyl)-9H-purine;(2R,3R,4R,5R)-2-(2-Amino-purin-9-yl)-5-hydroxymethyl-3-methyl-tetrahydro-furan-3,4-diol | | CAS: | 690269-87-5 | | MF: | C11H15N5O4 | | MW: | 281.27 | | EINECS: | | | Product Categories: | | | Mol File: | 690269-87-5.mol |  |
| | 2-AMino-9-(2-C-Methyl-β-D-ribofuranosyl)-9H-purine Chemical Properties |
| | 2-AMino-9-(2-C-Methyl-β-D-ribofuranosyl)-9H-purine Usage And Synthesis |
| Uses | 2-Ami no-9-(2-β-C-methyl-β-D-ribofuranosyl)-9H-purine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 2-AMino-9-(2-C-Methyl-β-D-ribofuranosyl)-9H-purine Preparation Products And Raw materials |
|